| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |